Status:
COMPLETED
Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.
Lead Sponsor:
Pfizer
Conditions:
Sexual Dysfunction, Physiological
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Outp...
Detailed Description
Medical Device Development
Eligibility Criteria
Inclusion
- Pre-menopausal healthy women aged 18-45 with regular, natural menstrual cycles.
- Subjects must be void of Female Sexual Disorder.
Exclusion
- Pregnant or lactating women
- Postmenopausal subjects
- Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric or neurologic disease.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00443027
Start Date
March 1 2007
End Date
October 1 2008
Last Update
May 28 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Dulwich, South Australia, Australia, 5065
2
Pfizer Investigational Site
Nedlands, Western Australia, Australia, 6009